Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind, placebo-controlled study of ONO-4641 in relapsing-remitting multiple sclerosis
2009-014339-19Phase 2Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in multiple sclerosis (MS) comparing ONO-4641 with Placebo (2 arms). Primary endpoint: Cumulative number of T1-weighted gadolinium-enhanced MRI lesions. Started Jan 2010; status: completed.
02
Drugs
ceralifimod
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2009-014339-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014339-19.